Facilitation of neurological recovery in a complete spinal cord injury with NeuroAiD: case report.

ABSTRACT:

Introduction

NeuroAiD (MLC601 & MLC901)'s neuroprotective capabilities include limiting exaggerated calcium influx, decreasing excitotoxicity, reducing oxidative stress, and preventing glutamate-induced cell death. It has also been shown to facilitate synaptogenesis, neurogenesis, and neuroplasticity. However, its clinical efficacy has primarily been studied in the context of brain injuries, particularly stroke. NeuroAiD's potential application in SCI remains largely untapped.

Case presentation

A 34-year-old male presented with C4 complete tetraplegia. Following surgical decompression and initial inpatient rehabilitation, he started consuming MLC901 two capsules three times daily at month 4 post injury for 6 months. He regained considerable neurological recovery following th

SUBMITTER: Zainudin MF 

PROVIDER: S-EPMC10991547 | biostudies-literature | 2024 Apr

REPOSITORIES: biostudies-literature